Prostate Cancer Foundation

VA, Prostate Cancer Foundation partner to expand clinical research

Thursday, December 1, 2016

The Department of Veterans Affairs (VA) has announced an important and substantial partnership with the Prostate Cancer Foundation (PCF) to prevent, screen and promote research to speed the development of treatments and cures for prostate cancer among Veterans. Announcement of the partnership was made during Launch Pad: Pathways to Cancer InnoVAtion, a joint VA/PCF summit that brings together world-class oncology experts, corporate and nonprofit partners to discuss research, big data, technology and clinical solutions to advance screening, diagnostics and care coordination for cancer and to promote the implementation of best practices across the VA healthcare system. 

[Read More]

Epic Sciences, Prostate Cancer Clinical Trials Consortium collaborate

Monday, March 9, 2015

Epic Sciences, a San Diego, Calif.-based developer of novel diagnostics to personalize and advance the treatment and management of cancer, and the Prostate Cancer Clinical Trials Consortium (PCCTC), a consortium for phase I/II and phase II clinical trials in prostate cancer, will collaborate to apply Epic’s circulating tumor cell (CTC) technology in multiple investigator-initiated clinical trials to advance the development of new prostate cancer treatments.

[Read More]